Cynvenio Gets SBIR Awards from NCI for CTC-based Tests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cynvenio Biosystems today announced it was awarded two contracts from the National Cancer Institute to develop lung cancer tests based on isolating mutation-bearing circulating tumor cells from whole blood.

Additionally, the Westlake Village, Calif.-based privately held company said that it received $1.2 million from existing shareholders as part of a $2 million financing authorized by its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.